KRISTIN ROBINSON: Open Payments
NPI 1225496466 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 8 payments from 6 companies in 2025. Trend: 2023 $181 · 2024 $129 · 2025 $231
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: COBENFY, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, VRAYLAR.
Industry payments across LA — which companies pay providers there.
